Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSFOMYCIN vs FOSFOMYCIN TROMETHAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSFOMYCIN vs FOSFOMYCIN TROMETHAMINE: Safety Overview

Metric FOSFOMYCIN FOSFOMYCIN TROMETHAMINE
Total FAERS Reports 828 778
Deaths Reported 128 24
Death Rate 15.5% 3.1%
Hospitalizations 407 280
Average Patient Age 55.3 yrs 59.2 yrs
% Female Patients 57.3% 83.9%
FDA Approval Date Oct 22, 2025 Dec 19, 1996
Manufacturer Meitheal Pharmaceuticals Inc. Cipla USA Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued